강내원 (Stanford University) | 한빛사논문 > 한빛사

한빛사논문

조회169

Stanford University

CV File 141 kb

J. Control. Release, Feb 26 2025, 380 S0168-3659(25)00163-4 | https://doi.org/10.1016/j.jconrel.2025.02.051 Repurposing verteporfin and hyaluronic acid gel for ocular surface treatment to prevent corneal scarring

Fang Chen ^a,1,2, Nae-Won Kang ^a,2, Thitima Wungcharoen ^a, Li Jiang ^a, Chris A. Basco ^a, Julian Garcia-Sanchez^a, Danting Lin ^a, Youngyoon Amy Seo ^a, Kyeongwoo Jang ^a, David Myung ^b,c, Wendy W. Liu ^a

^aSpencer Center for Vision Research, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA 94303, USA
^bDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA
^cDivision of Ophthalmology, Department of Veterans Affairs, Palo Alto Health Care System, Palo Alto, CA 94304, USA

¹Current address: Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
²These authors contributed equally to this work.
Corresponding authors: David Myung, Wendy W. Liu

Abstract

There is an unmet need for point-of-care therapies to prevent scarring and promote corneal clarity after injury, which is essential for maintaining vision. Verteporfin, an inhibitor of Yes-associated protein (YAP), has been shown to prevent fibrosis in several organs. Visudyne (VP) is an FDA-approved liposomal formulation of verteporfin used to treat abnormal blood vessels in the eye. Here, we showed that VP reduces myofibroblast formation in corneal stromal fibroblasts. To prolong the residence time of verteporfin on the ocular surface, the cohesive viscoelastic ProVisc® hyaluronic acid (HA) gel was hybridized to VP. This formulation is readily translatable because both VP and ProVisc® HA gel are FDA-approved agents. The ProVisc® HA gel increased the residence of subconjunctivally injected verteporfin 12-fold at 24 h after injection compared with pure VP. A single subconjunctival administration of VP hybridized within ProVisc® HA gel (VP/HA hydrogel) significantly reduced YAP activation, corneal fibrosis, neovascularization, and inflammation, leading to reduced opacity without compromising epithelial wound healing in mechanically injured rat corneas. This work demonstrated that VP hybridized with a viscoelastic HA gel can be readily repurposed to promote scar-less healing in the cornea.

논문정보

형식Research article
게재일2025년 02월 (BRIC 등록일 2025-03-09)
연구진국외 연구진
분야 의약학 > 약학

댓글 작성 로그인

CV 열람하기

연락처 보기